1. Signaling Pathways
  2. GPCR/G Protein
    MAPK/ERK Pathway
  3. Ras

Ras

Ras is the name given to a family of related proteins which is ubiquitously expressed in all cell lineages and organs. All Ras protein family members belong to a class of protein called small GTPase, and are involved in transmitting signals within cells. Ras is the prototypical member of the Ras superfamily of proteins, which are all related in 3D structure and regulate diverse cell behaviours. When Ras is 'switched on' by incoming signals, it subsequently switches on other proteins, which ultimately turn on genes involved in cell growth, differentiation and survival. As a result, mutations in ras genes can lead to the production of permanently activated Ras proteins. This can cause unintended and overactive signalling inside the cell, even in the absence of incoming signals. Because these signals result in cell growth and division, overactive Ras signaling can ultimately lead to cancer. The 3 Ras genes in humans (HRAS,KRAS, and NRAS) are the most common oncogenes in human cancer; Ras inhibitors are being studied as a treatment for cancer, and other diseases with Ras overexpression.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-146476
    KRAS inhibitor-18
    Inhibitor
    KRAS inhibitor-18 (compound 3-10) is a potent KRAS G12C inhibitor with an IC50 of 4.74 µM. KRAS inhibitor-18 shows p-ERK inhibition activities with IC50s of 66.4, 11.1 µM in MIA PaCA-2, A549 cells, respectively. KRAS inhibitor-18 has the potential for the research of pancreatic, colorectal, and lung cancers.
    KRAS inhibitor-18
  • HY-124161
    SCH54292
    Inhibitor
    SCH54292 is a potent Ras-GEF interaction inhibitor with IC50 of 0.7 μM.
    SCH54292
  • HY-168480
    SOS2 ligand 1
    Ligand
    SOS2 ligand 1(compound 2) is a selective ligand of son of sevenless 2 (SOS2) with an KD value of 4.6 µM.
    SOS2 ligand 1
  • HY-112666
    Farnesyl thiosalicylic acid amide
    Inhibitor
    Farnesyl thiosalicylic acid amide (FTS-A) is an orally active derivative of farnesyl thiosalicylic acid (HY-14754). Farnesyl thiosalicylic acid amide reduces Ras-GTP levels and inhibits cell growth with IC50s of 20 and 10 μM for Panc-1 and U87 cells, respectively. Farnesyl thiosalicylic acid amide can be used for the research of cancer.
    Farnesyl thiosalicylic acid amide
  • HY-115739
    RTIL 13
    Inhibitor
    RTIL 13 is a potent inhibitor of dynamin GTPase, with an IC50 of 2.3 μM for dynamin I GTPase. RTIL 13 also targets pleckstrin homology lipid binding domain. RTIL 13 can inhibit receptor-mediated and synaptic vesicle endocytosis, with IC50s of 9.3 μM and 7.1 μM, respectively.
    RTIL 13
  • HY-162971
    KRAS inhibitor-33
    Inhibitor
    KRAS inhibitor-33 (compound 115a) is an inhibitor of pyridopyrimidine kras (IC50 ≤ 100nM).
    KRAS inhibitor-33
  • HY-176870
    KRAS-IN-42
    Inhibitor
    KRAS-IN-42 (Compound Z1063) is a covalent KRASG12D mutants inhibitor. KRAS-IN-42 is promising for research of KRASG12D-mutant cancers (e.g., non-small cell lung cancer, colorectal cancer).
    KRAS-IN-42
  • HY-124514
    UC-857993
    Inhibitor
    UC-857993 is a selective SOS1-Ras inhibitor (Kd=14.7 μM, His6-SOS1cat), suppressing catalytic activity. UC-857993 also inhibits ERK and Ras activation, suppresses the growth of mouse embryonic fibroblasts (MEFs).
    UC-857993
  • HY-P11294
    KLVVVGADGVGKSALTI
    KLVVVGADGVGKSALTI is a KRAS G12D targeting peptide that can be used in tumor research.
    KLVVVGADGVGKSALTI
  • HY-153555
    KRAS G12D modulator-1
    Modulator
    KRAS G12D modulator-1 (compound 6) is a potent KRAS G12D modulator with IC50 values of 1-10 μM for NEA-G12D, PPI-G12D, and p ERK-AGS, respectively. KRAS G12D modulator-1 can be used in research of cancer.
    KRAS G12D modulator-1
  • HY-142945
    KRAS G12C inhibitor 43
    Inhibitor
    KRAS G12C inhibitor 43 (compound 59) is a potent KRAS G12C inhibitor. KRAS G12C inhibitor 43 shows antimigration and anti-proliferative activity with IC50s of 0.001-1 µM, >1 µM, >1 µM for H358, A549, HCC cells ,respectively.
    KRAS G12C inhibitor 43
  • HY-170550
    KRAS G12C inhibitor 69
    Inhibitor
    KRAS G12C inhibitor 69 (Compound K09) is the inhibitor for mutant RAS protein KRASG12C with an IC50 of 4.36 nM. KRAS G12C inhibitor 69 inhibits the ERK phosphorylation in NCI-H358 and MIA-PACA-2 with an IC50 of 12 nM and 7 nM. KRAS G12C inhibitor 69 inhibits the proliferation of cancer cell NCI-H358 and MIA-PACA-2 with IC50 of 3.15 nM and 2.33 nM.
    KRAS G12C inhibitor 69
  • HY-173329
    KRAS-IN-41
    Inhibitor
    KRAS-IN-41 is an inhibitor of KRAS with IC50 values of <0.01 μM for KRAS G12D and KRAS G12V. KRAS-IN-41 inhibits RAS mutant cell lines, GP2D (KRAS-G12D) and SW620 (KRAS-G12V). KRAS-IN-41 can be used in cancer research.
    KRAS-IN-41
  • HY-145047
    SOS1-IN-4
    Inhibitor
    SOS1-IN-4 is a potent SOS1 inhibitor with an IC50 of 56 nM for KRAS-C12C/SOS1 interaction (WO2021228028 A1, example 65).
    SOS1-IN-4
  • HY-147631
    KRAS G12C inhibitor 50
    Inhibitor
    KRAS G12C inhibitor 50 (Example 4) is a KRAS G12C inhibitor with an IC50 of 46.7 nM.
    KRAS G12C inhibitor 50
  • HY-162440
    pan-KRAS-IN-7
    Inhibitor
    pan-KRAS-IN-7 (Compound 25) is an inhibitor for in human tumor mutated genes KRAS, which inhibits proliferation of KRAS mutated cells AsPC-1 (G12D mutant) and SW480 (G12V mutant) with IC50 of 0.35 and 0.51 nM, respectively.
    pan-KRAS-IN-7
  • HY-172626
    KRAS G12D inhibitor 28
    Inhibitor
    KRAS G12D inhibitor 28 (Compound 1) is a KRAS G12D inhibitor. KRAS G12D inhibitor 28 (Compound 1) can be used in the cancer research.
    KRAS G12D inhibitor 28
  • HY-163720
    KRAS G12C inhibitor 63
    Inhibitor
    KRAS G12C inhibitor 63 (K45) is a KRAS G12C inhibitor. KRAS G12C inhibitor 63 can induce Apoptosis. KRAS G12C inhibitor 63 has antitumor activity.
    KRAS G12C inhibitor 63
  • HY-147636
    KRAS G12C inhibitor 55
    Inhibitor
    KRAS G12C inhibitor 55 (Compound 1) is a KRAS G12C inhibitor.
    KRAS G12C inhibitor 55
  • HY-147632
    KRAS G12C inhibitor 51
    Inhibitor
    KRAS G12C inhibitor 51 (example 1) is a KRAS G12C inhibitor.
    KRAS G12C inhibitor 51
Cat. No. Product Name / Synonyms Application Reactivity

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.